V
Vikram K Mahajan
Researcher at Government Medical College, Thiruvananthapuram
Publications - 159
Citations - 2176
Vikram K Mahajan is an academic researcher from Government Medical College, Thiruvananthapuram. The author has contributed to research in topics: Psoriasis & Medicine. The author has an hindex of 21, co-authored 146 publications receiving 1757 citations. Previous affiliations of Vikram K Mahajan include Indira Gandhi Medical College.
Papers
More filters
Journal ArticleDOI
Zinc therapy in dermatology: a review.
TL;DR: Although the role of oral zinc is well-established in human zinc deficiency syndromes including acrodermatitis enteropathica, it is only in recent years that importance of zinc as a micronutrient essential for infant growth and development has been recognized.
Journal ArticleDOI
Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India.
Nand Lal Sharma,Vikram K Mahajan,Anil Kanga,Anuradha Sood,Vishwa M. Katoch,Isabel Mauricio,Chauhan D. Singh,Uttam C. Parwan,Vivek Sharma,Ramesh Chander Sharma +9 more
TL;DR: Though rarely reported as a cause of LCL, L. donovani seems to be the predominant pathogen in this new focus of cutaneous leishmaniasis in Himachal Pradesh, where it is mainly endemic in the deserts of Rajasthan.
Journal ArticleDOI
Sporotrichosis: An Overview and Therapeutic Options
TL;DR: Sporotrichosis is a chronic granulomatous mycotic infection caused by Sporothrix schenckii that is endemic in tropical/subtropical areas and characteristically involves the skin and subcutaneous tissue following traumatic inoculation of the pathogen.
Journal ArticleDOI
Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
TL;DR: Pemphigus, a common immunobullous disease of skin and mucous membranes affecting both sexes of all ages, was almost fatal before the advent of corticosteroids and recent introduction of adjuvant therapy improved its prognosis.
Journal ArticleDOI
Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
TL;DR: This article is intended to be a primer for dermatologists in their understanding of clinical relevance of PPARs and PPAR agonists in dermatology therapeutics.